Martin Whitman - Third Avenue Management
Holding/activity history for Collegium Pharmaceutical Inc. (COLL)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 155,143 | 0.83 | Reduce 23.73% | 0.41 | $33.07 | $5,130,579 | SEC |
| 2025 Q4 | 203,401 | 1.71 | $46.30 | $9,417,466 | SEC | ||
| 2025 Q3 | 203,401 | 1.34 | $35.17 | $7,153,613 | SEC | ||
| 2025 Q2 | 203,401 | 1.24 | $29.57 | $6,014,568 | SEC | ||
| 2025 Q1 | 203,401 | 1.22 | $29.85 | $6,071,520 | SEC | ||
| 2024 Q4 | 203,401 | 1.13 | Add 11.36% | 0.12 | $28.65 | $5,827,439 | SEC |
| 2024 Q3 | 182,651 | 1.15 | Add 0.20% | <0.01 | $38.64 | $7,057,635 | SEC |
| 2024 Q2 | 182,281 | 1.01 | Add 68.59% | 0.41 | $32.20 | $5,869,448 | SEC |
| 2024 Q1 | 108,120 | 0.67 | Add 30.08% | 0.15 | $38.82 | $4,197,218 | SEC |
| 2023 Q4 | 83,120 | 0.42 | Buy | 0.42 | $30.78 | $2,558,434 | SEC |